🇺🇸 FDA
Patent

US 11173159

Methods and compositions for inhibition of polymerase

granted A61KA61K31/196A61K31/215

Quick answer

US patent 11173159 (Methods and compositions for inhibition of polymerase) held by BioCryst Pharmaceuticals, Inc. expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/196, A61K31/215, A61K31/351, A61K31/519